Tokyo police have arrested three people on suspicion of buying shares in Japanese biotechnology and drug startup Tella Inc. on the basis of undisclosed information on the company's planned development of a COVID-19 treatment.
The Metropolitan Police Department arrested Toshiaki Kubota, the 53-year-old president of a construction company, and two others on Friday for alleged involvement in insider trading in violation of the Financial Instruments and Exchange Act.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
PHOTO GALLERY (CLICK TO ENLARGE)
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.